Researchers reveal abnormal myokine signaling in congenital myotonic dystrophy

December 12, 2017, Osaka University
Aberrant CpG methylation upstream of the expanded CTG repeats dysregulates transcription at the repeat locus in both directions, thereby increasing toxic RNA burden. Additionally, enhanced RNA toxicity upregulated the interleukin-6 (IL-6) myokine signaling pathway, which is involved in myocyte maturation and muscle atrophy, resulting in severe CDM phenotypes. Credit: Osaka University

Myotonic dystrophy (DM) is the most common form of genetic muscular dystrophy that begins in adulthood. DM is characterized by progressive muscle wasting and weakness. People with this disorder often have prolonged muscle contractions (myotonic) and are not able to relax certain muscles after use.

DM has genetically distinct type 1 (DM1) and type 2 (DM2), caused by a toxic gain of function of expanded CUG and CCUG nucleotide repeats, respectively. Nucleotides are organic molecules that serve as the building blocks for forming the genetic material DNA and RNA. Although both disorders are clinically similar, congenital DM (CDM), a severe DM form, is found only in DM1. Notably, CDM – as the name implies – is found only in early life, suggesting specific pathological mechanisms. However, the mechanisms remain largely unexplained.

"We ponder why only expanded CTG repeats in the DMPK and not CCTG repeats in the CNBP gene result in CDM, and how highly methylated CpG sites around the expanded repeats contribute to the disease process, and what causes severe muscle immaturity in CDM," Masayuki Nakamori, lead author of an Osaka University-centered study that investigated the specific mechanisms responsible for CDM explains.

To address the questions, the research team performed a comprehensive study dissecting the histology, repeat size, CpG methylation, alternative splicing, and gene expression of CDM skeletal muscles and cell models. They found an upregulation of the interleukin-6 (IL-6) myokine signaling pathway in CDM muscles, and a correlation between muscle immaturity with IL-6 expression. Myokines are essentially cytokines (important small proteins responsible for cell signaling) that are produced and released by muscle cells (myocytes) in response to muscular contractions.

Because the IL-6 pathway is involved in both myocyte maturation and muscle degeneration, the results indicate that enhanced RNA toxicity contributes to severe CDM phenotypes through aberrant IL-6 signaling. The findings were recently published in Cell Reports.

"The disease process of CDM has yet to be elucidated because of the difficulty of obtaining enough and appropriate samples for analysis," says co-author Hideki Mochizuki. "In this study, despite the limitation, we successfully obtained ten CDM samples from identical muscles in different patients of similar age. This allows us to investigate the specific pathomechanisms of CDM, which yielded results that support the possibility of treatment for CDM through interventions in IL-6 (the NF-kB) signaling pathways, which have been applied successfully for other diseases, including rheumatoid arthritis."

Explore further: Researchers find genetic factors that cause muscle weakness, wasting disorder

More information: Masayuki Nakamori et al. Aberrant Myokine Signaling in Congenital Myotonic Dystrophy, Cell Reports (2017). DOI: 10.1016/j.celrep.2017.10.018

Related Stories

Researchers find genetic factors that cause muscle weakness, wasting disorder

July 11, 2017
For years, the underlying process that causes a debilitating muscle disorder in infants and young children has been largely unknown. Now, a group that includes University of Florida Health genetics researchers has identified ...

Designed proteins to treat muscular dystrophy

June 28, 2017
The cell scaffolding holds muscle fibers together and protects them from damage. Individuals who suffer from muscular dystrophy often lack essential components in this cell scaffold. As a result, their muscles lack strength ...

Study identifies potential drug targets for muscular dystrophy treatments

January 9, 2017
Myotonic dystrophy type I (MD1) is a common form of muscular dystrophy associated with muscle wasting, weakness, and myotonia. These symptoms are linked to the accumulation of toxic gene transcripts in muscle cells that result ...

Researcher draws bulls eye around muscular dystrophy drug targets

November 7, 2017
In a recent paper published in the journal Skeletal Muscle, a Saint Louis University researcher reports success in identifying new drug targets that potentially could slow or halt the progression of a form muscular dystrophy, ...

Antisense oligonucleotides make sense in myotonic dystrophy

February 27, 2012
Antisense oligonucleotides – short segments of genetic material designed to target specific areas of a gene or chromosome – that activated an enzyme to "chew up" toxic RNA (ribonucleic acid) could point the way ...

Study finds flu ravages muscles of zebrafish with muscular dystrophy

October 26, 2017
This time of year, doctors often recommend flu shots for people who are young, old, pregnant or immunocompromised.

Recommended for you

Female biology – two X chromosomes and ovaries – extends life and protects mice from aging

December 18, 2018
Around the world, women outlive men. This is true in sickness and in health, in war and in peace, even during severe epidemics and famine. In most animal species, females live longer than males.

Sugar targets gut microbe linked to lean and healthy people

December 18, 2018
Sugar can silence a key protein required for colonization by a gut bacterium associated with lean and healthy individuals, according to a new Yale study published the week of Dec. 17 in the journal Proceedings of the National ...

Get a warrant: Researchers demand better DNA protections

December 18, 2018
New laws are required to control access to medical genetic data by law enforcement agencies, an analysis by University of Queensland researchers has found.

Wound care revolution: Put away your rulers and reach for your phone

December 18, 2018
Monitoring a wound is critical, especially in diabetic patients, whose lack of sensation due to nerve damage can lead to infection of a lesion and, ultimately, amputation. Clinicians and healthcare professionals at the McGill ...

Using light to stop itch

December 17, 2018
Itch is easily one of the most annoying sensations. For chronic skin diseases like eczema, it's a major symptom. Although it gives temporary relief, scratching only makes things worse because it can cause skin damage, additional ...

Law professor suggests a way to validate and integrate deep learning medical systems

December 13, 2018
University of Michigan professor W. Nicholson Price, who also has affiliations with Harvard Law School and the University of Copenhagen Faculty of Law, suggests in a Focus piece published in Science Translational Medicine, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.